Novo Nordisk A/S
NVOFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
43,560
Cost of Revenue
6,678
Gross Profit
36,882
Gross Margin
84.7%
Operating Income
19,251
Operating Margin
44.2%
Net Income
15,148
Net Margin
34.8%
EPS (Basic)
$22.67
EPS (Diluted)
$22.63
EBITDA
20,606
EBITDA Margin
47.3%
2023
12/31/2023
Revenue
34,839
Cost of Revenue
5,365
Gross Profit
29,474
Gross Margin
84.6%
Operating Income
15,386
Operating Margin
44.2%
Net Income
12,552
Net Margin
36.0%
EPS (Basic)
$18.67
EPS (Diluted)
$18.62
EBITDA
17,194
EBITDA Margin
49.4%
2022
12/31/2022
Revenue
26,543
Cost of Revenue
4,267
Gross Profit
22,276
Gross Margin
83.9%
Operating Income
11,221
Operating Margin
42.3%
Net Income
8,329
Net Margin
31.4%
EPS (Basic)
$12.26
EPS (Diluted)
$12.22
EBITDA
11,520
EBITDA Margin
43.4%
2021
12/31/2021
Revenue
21,120
Cost of Revenue
3,549
Gross Profit
17,571
Gross Margin
83.2%
Operating Income
8,797
Operating Margin
41.7%
Net Income
7,164
Net Margin
33.9%
EPS (Basic)
$10.40
EPS (Diluted)
$10.37
EBITDA
9,809
EBITDA Margin
46.4%
2020
12/31/2020
Revenue
19,042
Cost of Revenue
3,140
Gross Profit
15,902
Gross Margin
83.5%
Operating Income
8,119
Operating Margin
42.6%
Net Income
6,321
Net Margin
33.2%
EPS (Basic)
$9.03
EPS (Diluted)
$9.01
EBITDA
8,891
EBITDA Margin
46.7%